# Study On The Performance And Safety Of The REVISYON SDS 100 Device On Visual Acuity In Subjects With Cataract

> **NCT05396547** · NA · COMPLETED · sponsor: **Edinburgh Biosciences Ltd** · enrollment: 114 (actual)

## Conditions studied

- Age-related Cataract

## Interventions

- **DEVICE:** Treated with REVISYON SDS 100 Device

## Key facts

- **NCT ID:** NCT05396547
- **Lead sponsor:** Edinburgh Biosciences Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-28
- **Primary completion:** 2025-01-04
- **Final completion:** 2025-02-02
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2025-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05396547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05396547, "Study On The Performance And Safety Of The REVISYON SDS 100 Device On Visual Acuity In Subjects With Cataract". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05396547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*